It appears that an unknown number of people had natural immunity to COVID-19 from exposure to SARS or previous coronaviruses.
Study: Covid-19: Do many people have pre-existing immunity?
“Overall, our results indicate that mild infection with SARS-CoV-2 induces robust antigen-specific, long-lived humoral immune memory in humans.”
and
“Individuals who have recovered from COVID-19 have a substantially lower risk of reinfection with SARS-CoV-2”
SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans
“A previous history of SARS-CoV-2 infection was associated with an 84% lower risk of infection, with median protective effect observed 7 months following primary infection. This time period is the minimum probable effect because seroconversions were not included. This study shows that previous infection with SARS-CoV-2 induces effective immunity to future infections in most individuals.”
SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)
“Overall, positive baseline anti-spike antibodies were associated with lower rates of PCR-positivity (with or without symptoms) (adjusted rate ratio 0.24 [95%CI 0.08-0.76, p=0.015]). Rate ratios were similar using anti-nucleocapsid IgG alone or combined with anti-spike IgG to determine baseline status.”
Antibodies to SARS-CoV-2 are associated with protection against reinfection
“This quantitative study of plasma cell longevity demonstrates that plasma cells can survive for periods longer than 1 year. In addition, this study also relates the lifespan of antigen-specific plasma cells located in different anatomical sites to the level of specific antibody observed in the serum.”
Humoral Immunity Due to Long-Lived Plasma Cells
“Taken together, these results show that antibody responses, especially IgG antibody, were not only durable in the vast majority of patients in the 250 day period, but also that the bi-phasic decay curve suggests the generation of longer lived plasma cells producing antibody to the SARS-CoV-2 spike protein.”
And
“these data showing such stable antibody titers are best explained by the persistence of long-lived plasma cells in the bone marrow many years after infection.”
And
“Taken together, these results show that people infected with SARS-CoV-2 may have also have some heightened immunity against the common human betacoronaviruses and more importantly against SARS-CoV-1.”
And
“Taken together, our findings show that induction of neutralizing antibodies occurs in the majority of COVID-19 patients. These neutralizing antibodies can persist over the 8–9 month period following infection, and show a correlation with spike and RBD binding IgG.”
And
“That the CD8+ T cell differentiation program after COVID-19 infection resembles what is seen after YFV infection of human suggests that COVID-19 patients may also generate long-lived CD8+ T cell memory.”
And
“Our study demonstrates the considerable immune heterogeneity in the generation of potentially protective response against SARS-CoV-2, and by focusing on the dynamics and maintenance of B and T cell memory responses, we were able to identify features of these early cellular responses that can forecast the durability of a potentially effective antibody response.”
Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells
- Article: Why the CDC Ignores Natural Immunity
- Article: NYT: Fauci admits to deceiving the public about herd immunity because he wanted more people to get vaccinated
- Article: Could Covid-19 immunity last for 17 YEARS? Researchers find SARS patients still have crucial T cells from when they were infected in 2003
- Vaccinating people who have had covid-19: why doesn’t natural immunity count in the US?
- Video: Natural versus vaccine immunity, Dr. John Campbell
- Post infection natural immunity, debate and implications for mandatory vaccination https://www.bmj.com/content/374/bmj.n…
- Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection https://www.science.org/doi/10.1126/s…
- Substantial immune memory is generated after COVID-19
- About 95% of subjects retained immune memory at ~6 months after infection
- Video: Pfizer Scientist: ‘Your Antibodies are Probably Better than the Vaccination’
- Study: SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)
- Video: Why I HAVEN’T yet taken the COVID VACCINE, Cardiologist Dr. James Marcum
- Study: Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
- Study: T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV
- Testing: T cells know if you had COVID-19.
- Video: Natural Immunity Update // No Vaccine Yet
- Videos: Natural Immunity Playlist, Dr. Keith Moran
- Article: Here are the studies that show natural immunity provides effective protection from COVID-19
- Video: COVID-19 PCR & Antibodies Testing with Dr. Ryan Cole, MD FCAP, Dr. Ryan Cole
- Article: COVID-Recovered Don’t Need the Vaccine, Says Dr. Peter McCullough
- Article: The Truth About Natural Immunity
- Study: SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans 2021 May 24
- Study: Long-Lived Plasma Cells Are Contained within the CD19−CD38hiCD138+ Subset in Human Bone Marrow
- Study: The generation of antibody-secreting plasma cells
- Article: Dr. Sanjay Gupta to Dr. Fauci—‘What about Natural Immunity?’
- Study: Humoral Immunity Due to Long-Lived Plasma Cells
- Study: Long-Lived Plasma Cells Are Contained within the CD19−CD38hiCD138+ Subset in Human Bone Marrow
- Study: Evolution of antibody immunity to SARS-CoV-2
- Article: Jaw-Dropping Academic Study Shows Natural Immunity Superior to COVID Vaccine
- Study: Natural Immunity After COVID-19 Found Durable and Robust
- Study: Mucosal Immunity in Terms of SARS-CoV-2 Antibodies in Saliva After COVID-19 Infection and Vaccination
- Study: Immune T Cells May Offer Lasting Protection Against COVID-19
- Article: ICAN EVISCERATES CDC IN FORMAL EXCHANGE REGARDING NATURAL IMMUNITY
- Article: Recovered immunity is weak “Because science”/CDC
- Study: Quantifying the risk of SARS-CoV-2 reinfection over time
- Study: SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
- Study: SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19
- Study: Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans
- Study: Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases
How Long Does Natural Immunity Last?
At Least: